University Hospital Bern
Bern, Canton of Bern, 3010, Switzerland
NCT Number: NCT04764799
The HEAVEN criteria were found valid to predict difficult airways during preclinical emergency intubations in a retrospective study. The acronym stands for Hypoxemia, Extremes of size, Anatomic abnormalities, Vomit/blood/fluid, Exsanguination/anaemia, and Neck mobility issues. This is a monocentric prospective observational study to assess the validity of the HEAVEN criteria in the in-hospital setting at a level I adult and pediatric emergency university-based hospital.
Looking for future studies?
Notify MeAll sexes
Observational
Bern, Canton of Bern, 3010, Switzerland
Emergency intubations are prone to present a difficult airway. A difficult airway can lead to prolonged intubation time and to hypoxemia in situations where oxygenation is not possible that can finally result in hypoxic cardiac arrest and irreversible brain damage caused by hypoxic ischemic encephalopathy.
Tools to predict difficult airways are rather poor concerning specificity and sensitivity. A score to predict difficult airway developed in the pre-clinical setting are the HEAVEN criteria. The acronym HEAVEN stands for: Hypoxemia, Extremes of size, Anatomic abnormalities, Vomit/blood/fluid, Exsanguination/anaemia, and Neck mobility issues and does not need patients' cooperation. It has been recently validated in the pre-clinical emergency setting and was found to be useful.
The study aim is to evaluate if the HEAVEN criteria are suitable to be used to predict difficult airway in in-hospital emergency intubation to finally increase patients' safety during rapid sequence induction (RSI).
This prospective observational single-centre study in emergency intubation will consecutively recruit all patients of all ages who need RSI due to their medical condition performed by the staff of the Department of Anaesthesiology and Pain Medicine at the Bern University Hospital. We will record data that are gathered during routine patient care and stored primarily in the departmental anaesthesia information systems.
The primary objective is to validate if the HEAVEN criteria, an existing prehospital difficult airway prediction tool, is able to predict airways difficulties during RSI in the clinical in-hospital setting. The secondary objective is, to assess the subcomponent of the HEAVEN criteria and if differences and adaptations are needed comparing it to the prehospital setting.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Rapid sequence induction starts with the administration of rapid acting intravenous narcotics, opioids and neuromuscular blockage and avoids whenever possible positive-pressure ventilation after induction of anesthesia.
Time frame: 1 hour
Every attempt starts with the insertion of a laryngoscope blade over the lips and ends with a blocked tube in the trachea and measuring of carbon dioxide (CO2)
Time frame: 1 hour
Rated on a scale by the airway manager: easy, difficult, not possible
Time frame: 1 hour
All RSI during the study period are analyzed for success (If intubation is possible or not)
Time frame: 1 hour
Saturation will be measured and recorded during the whole intervention and analyzed for the time of the RSI.
Time frame: 1 hour
Every attempt starts with the insertion of a laryngoscope blade over the lips and ends with a blocked tube in the trachea and measuring of CO2
Time frame: 1 hour
C&L for direct laryngoscopy or POGO for video laryngoscopy will be recorded for every intubation
Time frame: 1 hour
Heart rate will be measured and recorded during the whole intervention and analyzed for the time of the RSI.
Time frame: 1 hour
BP will be measured and recorded during the whole intervention and analyzed for the time of the RSI.
Time frame: 1 hour
SpO2 will be measured and recorded during the whole intervention and analyzed for the time of the RSI.
Time frame: 1 hour
Use of vasoconstrictors will be recorded during the whole intervention and analyzed for the time of the RSI.
Time frame: 1 hour
Use of:
Time frame: 1 hour
Yes / No, if Yes, specify: Succinylcholine, Rocuronium, Atracurium, other
Time frame: 1 hour
Patient's age, gender, weight and size
Time frame: 1 day
type of surgery by discipline (e.g. ear, nose and throat (ENT), visceral, orthopedic, heart, urology, gynecology) and specification (e.g. appendectomy)
Time frame: 1 day
The place where the intubation is performed. Either operation room (OR) or outside OR
Time frame: 1 hour
the exact time (HH:MM:SS) in central european time of the induction of the RSI
Time frame: 1 hour
nurse, resident or attending anaesthesiologist
Time frame: 1 hour
Type and size of the used ETT(s) during the RSI attempt(s)
Time frame: 1 hour
Will be directly recorded if occurred during the RSI by the airway manager or team
Time frame: 1 day
All patients will be visited in the first 24 hours after anaesthesia if they report subjectively airway-related complains like hoarseness or problems with swallowing until 24 hours after intubation and evaluated by an anaesthesiologist or further referred to an ENT specialist
Time frame: 1 day
Newly recorded suspicion of aspiration during intubation will be recorded by the airway team
Thomas Riva
Other
HEAVEN Criteria: a Monocentric Prospective Observational Study to Validate the Prediction of Difficult Airway for In-Hospital Emergency Airway Management
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07376525
Mechanical Ventilation, Respiration Disorders
Istanbul, Sisli, Turkey (Türkiye)
View Trial DetailsNCT07411976
Critical Illness, Disease Attributes
Nîmes, France
View Trial DetailsNCT07658131
Critical Illness, Disease Attributes
Taichung, Taiwan
View Trial DetailsNCT07620912
Chronic Disease, Chronic Obstructive Pulmonary Disease
Asyut, Egypt
View Trial Details